Get started
Author

Marina Lee

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
2022 · Kirsten E. Lyke, Robert L. Atmar, et al. · Cell Reports Medicine · 153
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
2023 · Angela R. Branche, Nadine G. Rouphael, et al. · Nature Medicine · 61
PDF
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
2023 · Kirsten E. Lyke, Robert L. Atmar, et al. · npj Vaccines · 33
PDF
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
2022 · Angela R. Branche, Nadine G. Rouphael, et al. · medRxiv · 29
PDF
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults
2023 · Deborah A. Theodore, Angela R. Branche, et al. · JAMA Network Open · 22
PDF
Risk of COVID-19 after natural infection or vaccination
2023 · Anne-Marie Rick, Matthew B. Laurens, et al. · EBioMedicine · 18
PDF
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir
2024 · Kanal Singh, Kevin Rubenstein, et al. · The Journal of Infectious Diseases · 15
PDF
Daily fosfomycin versus levofloxacin for complicated urinary tract infections
2023 · Nadine Rouphael, Patricia Winokur, et al. · mBio · 13
Patient satisfaction with procedural sedation in the emergency department
2017 · Olivia G Johnson, David McD Taylor, et al. · Emergency Medicine Australasia · 12
Variables associated with administration of analgesia, nurse-initiated analgesia and early analgesia in the emergency department
2016 · David McD Taylor, Jessie Chen, et al. · Emergency Medicine Journal · 11
PDF
Observational study of alternative therapies among paediatric emergency department patients
2017 · Juen‐Li Ding, David McD Taylor, et al. · Emergency Medicine Australasia · 9
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
2024 · Ilias I. Siempos, Andre C. Kalil, et al. · EClinicalMedicine · 8
PDF
The association between abnormal vital sign groups and undesirable patient outcomes
2018 · Marina Lee, David McD Taylor, et al. · Hong Kong Journal of Emergency Medicine · 8
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data
2025 · Leah I. B. Andrews, M. Elizabeth Halloran, et al. · JAMA Network Open · 7
PDF
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals
2024 · Leigh H. Fisher, Jia Jin Kee, et al. · JAMA Network Open · 7
The effect of provision of pain management advice on patient satisfaction with their pain management: a pilot, randomised, controlled trial (pain advice trial)
2016 · David McD Taylor, Olivia Grover Johnson, et al. · Emergency Medicine Journal · 7
PDF
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
2024 · Youyi Fong, Lauren Dang, et al. · Clinical Infectious Diseases · 3
PDF
Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres
2024 · Peter Hoskin, Marina Lee, et al. · BMC Cancer · 3
PDF
Metastatic Breast Cancer To Ovaries And Endometrium: A Rare Case
2025 · Mariana Rocha Bohne, Georgia Fontes Cintra, et al. · International Journal of Gynecological Cancer · 1
PDF
An open-label phase Ib time-to-event continual reassessment method of dose-escalation of tolinapant (ASTX660) in combination with standard radical chemotherapy and radiotherapy in patients with cervical cancer
2022 · Marina Lee, Peter Hoskin, et al. · http://isrctn.com/
Implications of differences between elm-inhabiting phytoplasmas and others in 16S RNA group 5
1997 · Griffiths, H.M., Sinclair, W.A., et al. · HAL
Works count: 23
Citation count: 420
H-index: 10
I10-index: 10
Year
Topic
Type